Surgery Websites
Hepatobiliary & Pancreatic Surgery »  Meet the Team »  Hepatology »  Norah A. Terrault, M.D., M.P.H.
Norah A. Terrault, M.D., M.P.H.

Norah A. Terrault, M.D., M.P.H.

  • Professor of Clinical Medicine & Surgery
  • Departments of Medicine & Surgery
  • Director of Viral Hepatitis Research in Liver Transplantation

Contact Information

Academic Office
 Division of Gastroenterology
513 Parnassus Avenue, Room S-357
San Francisco, CA 94143-0358
Phone: (415) 476-2227
415-476-0659
norah.terrault@ucsf.edu
 
Open Popup

Education

1985 B.MSc., University of Alberta

1987 M.D., University of Alberta

1997 M.P.H. University of California, Berkeley

Residencies

  • 1987-88 Internship, University of Toronto
  • 1988-91 Internal Medicine, University of Toronto
  • 1991-93 Gastroenterology, University of Toronto

Fellowships

  • 1994-95 Clinical Hepatology, Division of Gastroenterology, University of Toronto

  • 1995-97 Research Hepatology, Division of Gastroenterology, UCSF Medical Center

Board Certifications

  • American Board of Internal Medicine, Internal Medicine
  • American Board of Internal Medicine, Gastroenterology

Program Affiliations

  • UCSF Liver Center

Clinical Expertise

Research Interests

  • Hepatitis B virus (HBV)
  • Hepatitis C virus (HCV)
  • Liver Injury and Repair

Biography

Dr. Norah Terrault is a hepatologist or liver specialist who is recognized internationally for the treatment of viral hepatitis and liver transplantation. Her research includes the study of viral hepatitis and its progression and treatment, especially in liver transplant patients. Her research includes several clinical trials related to preventing and treating chronic hepatitis C and B. Her studies in this area have been presented to the American Association for the Study of Liver Diseases, the leading organization for research in liver disease.

Terrault completed medical training at the University of Alberta and specialty medical training in Internal Medicine and Gastroenterology at the University of Toronto, both in Canada. Her post-doctoral fellowship in hepatology and viral hepatitis was completed at the University of California, San Francisco while earning a concurrent master's degree in public health from the University of California at Berkeley. She joined the medical staff at UCSF Medical Center in 1997.

Research Overview

My research focuses on the natural history and treatment of hepatitis C virus (HCV) and hepatitis B virus (HBV), particularly in special populations, including those undergoing liver transplantation. Work in progress addresses the natural history of post-transplant disease and specific therapies to prevent infection or modify HCV and HBV disease progression and loss of grafts from recurrent disease.

Our virological analyses are focused on characterization of viral mutations that occur in liver transplant recipients receiving antiviral therapies and assessment of the effect of these variant viruses on the natural history and severity of disease post-transplantation. Knowledge of these factors may allow improved organ allocation by identifying subsets of patients with HCV recurrence in liver grafts who would be favorable or unfavorable candidates for retransplantation. 

Research & Funding

Data provided by UCSF Profiles, powered by CTSI
ORCID iD: 0000-0003-4143-1950 Additional info
  • USC Cirrhosis Clinical Center
    Sponsor:
    Sponsor ID:
    Funding Period:
    Sep 2021
    -
    Aug 2026
    Principal Investigator
  • Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN)
    Sponsor:
    Sponsor ID:
    Funding Period:
    Jun 2002
    -
    Jun 2024
    Principal Investigator
  • Hepatitis B Research Network (HBRN): Natural History and Treatment Studies
    Sponsor:
    Sponsor ID:
    Funding Period:
    Sep 2008
    -
    May 2020
    Principal Investigator
  • Bay Area Hepatitis C Cooperative Research Center
    Sponsor:
    Sponsor ID:
    Funding Period:
    Jun 2010
    -
    May 2015
    Co-Investigator
  • General Clinical Research Center
    Sponsor:
    Sponsor ID:
    Funding Period:
    Dec 1974
    -
    Mar 2009
    Co-Investigator
  • Resistance to Antiviral Therapy in Chronic Hepatitis C
    Sponsor:
    Sponsor ID:
    Funding Period:
    Aug 2001
    -
    Apr 2007
    Principal Investigator

Clinical Trials

Data provided by UCSF Profiles, powered by CTSI

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 367
Data provided by UCSF Profiles, powered by CTSI
  1. Terrault NA, Slepin J, Kanner R, Gailloux K, Catalli L, McKinney J, Straley S, Morris P, Hluhanich R, Gonzalez-Flores A, Dodge J, Sarkar S. Strategies to Increase Primary Care Provider Capacity for Hepatitis C Care: The California ECHO-PLUS Study. J Viral Hepat. 2023 Jan 25. View in PubMed
  2. Hsu CC, Dodge JL, Weinberg E, Im G, Ko J, Davis W, Rutledge S, Dukewich M, Shoreibah M, Aryan M, Vosooghi A, Lucey M, Rice J, Terrault NA, Lee BP. Multi-Centered study of patient outcomes after declined for early liver transplantation in severe Alcohol-associated hepatitis. Hepatology. 2023 Jan 19. View in PubMed
  3. Feld JJ, Wahed AS, Fried M, Ghany MG, Di Bisceglie AM, Perrillo RP, Khalili M, Yang X, Belle SH, Janssen H, Terrault N, Lok AS, Hepatitis B Research Network (HBRN). Withdrawal of long-term nucleotide analogue therapy in chronic hepatitis B: Outcomes from the withdrawal phase of the HBRN immune active treatment trial. Am J Gastroenterol. 2023 Jan 13. View in PubMed
  4. Lim SG, Baumert TF, Boni C, Gane E, Levrero M, Lok AS, Maini MK, Terrault NA, Zoulim F. The scientific basis of combination therapy for chronic hepatitis B functional cure. Nat Rev Gastroenterol Hepatol. 2023 Jan 11. View in PubMed
  5. Kardashian A, Dodge JL, Terrault NA. Quantifying the Negative Impact of Fast-food Consumption on Liver Steatosis Among United States Adults with Diabetes and Obesity. Clin Gastroenterol Hepatol. 2023 Jan 10. View in PubMed
  6. View All Publications

Videos

Data provided by UCSF Profiles, powered by CTSI
  1. Kidney Transplant Update - Hepatitis C and Steroid Sparing
  2. Management of Hepatitis C in the Pre-Transplant Patient
  3. Advances in Treatment for HCC, Sorafenib (HCC) Dawn of a New Era
  4. Treatment of Hep C Pre and Post Transplant and the Obese Patient with End-stage Liver Disease

In the News

  • New AASLD Video Showcases UCSF Liver Transplant Program

    UCSF Transplant Surgery - December 20, 2014
    Transplant Logo
    A new video on AASLD TV (American Association for the Study of Liver Diseases) features the UCSF Liver Transplant Program and faculty John P. Roberts, M.D., Norah A. Terrault, M.D., M.P.H. and Francis Y.K. Yao, M.D. As a leader in the treatment of liver disease and transplantation, UCSF has performed more than 2,500 liver transplants in both children and adults, many in their growing living donor liver transplantation program. The UCSF team is also  researching cures for hepatitis as well as [...]

 

 
Site Directory
    X